WST
West Pharmaceutical Services Inc
Price:  
355.64 
USD
Volume:  
434,699.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

WST EV/EBITDA

-21.1%
Upside

As of 2024-05-19, the EV/EBITDA ratio of West Pharmaceutical Services Inc (WST) is 31.63. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WST's latest enterprise value is 25,509.22 mil USD. WST's TTM EBITDA according to its financial statements is 806.50 mil USD. Dividing these 2 quantities gives us the above WST EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 17.0x - 19.5x 19.1x
Forward P/E multiples 22.1x - 27.9x 24.0x
Fair Price 193.88 - 397.58 280.43
Upside -45.5% - 11.8% -21.1%
355.64 USD
Stock Price
280.43 USD
Fair Price

WST EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-17 31.63
2024-05-16 31.49
2024-05-15 31.26
2024-05-14 31.52
2024-05-13 31.86
2024-05-10 32.40
2024-05-09 32.53
2024-05-08 32.62
2024-05-07 32.78
2024-05-06 32.61
2024-05-03 32.48
2024-05-02 32.79
2024-05-01 32.33
2024-04-30 31.80
2024-04-29 31.52
2024-04-26 32.06
2024-04-25 32.76
2024-04-24 34.35
2024-04-23 34.75
2024-04-22 33.41
2024-04-19 33.11
2024-04-18 33.59
2024-04-17 33.59
2024-04-16 33.78
2024-04-15 33.72
2024-04-12 33.83
2024-04-11 34.51
2024-04-10 34.71
2024-04-09 34.95
2024-04-08 34.97
2024-04-05 35.10
2024-04-04 34.38
2024-04-03 34.48
2024-04-02 34.54
2024-04-01 35.27
2024-03-28 35.25
2024-03-27 35.10
2024-03-26 34.57
2024-03-25 34.59
2024-03-22 35.09
2024-03-21 35.26
2024-03-20 35.10
2024-03-19 35.25
2024-03-18 35.25
2024-03-15 34.52
2024-03-14 35.58
2024-03-13 34.35
2024-03-12 33.65
2024-03-11 31.80
2024-03-08 31.93